Skip to content
Application 210434
- Type
- ANDA
- Sponsor
- CIPLA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ALBENDAZOLE | ALBENDAZOLE | TABLET;ORAL | 200MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69097-237 | ALBENDAZOLE | albendazole | Cipla USA Inc. | ANDA | Current |
| 69097-237 | ALBENDAZOLE | albendazole | Cipla USA Inc. | ANDA | Current |
| 69097-237 | ALBENDAZOLE | albendazole | Cipla USA Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 55616 | ORIG | 2018-09-25 |